Jonathan Schechter
Director at PharmaCyte Biotech, Inc. (PMCB); Director at Oblong, Inc. (TWAV)
Purchase track record
Below average. Based on 2 purchases with a full 90 days of price history.
8
Avg. 90-day return-38.3%
vs. S&P 500-37.6%
Beat the market0%
Paper profit on buys−$28K
Total bought / sold$67K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jan 7SEC | PMCBPharmaCyte Biotech, Inc. | Buy | 20,000152,500 held (+15%) | $0.78 | $16K | -48.2% |
| Jan 7SEC | PMCBPharmaCyte Biotech, Inc. | Buy | 20,000172,500 held (+13%) | $0.79 | $16K | -48.8% |
| Jan 7SEC | PMCBPharmaCyte Biotech, Inc. | Buy | 20,000192,500 held (+12%) | $0.84 | $17K | -51.9% |
| Nov 17SEC | TWAVOblong, Inc. | Buy | 10,00025,000 held (+67%) | $1.91 | $19K | -23.0% |
- Buy
Director Jonathan Schechter bought $16K of PMCB at $0.78 — first open-market purchase in our records.
- Buy
Director Jonathan Schechter bought $17K of PMCB at $0.84 — largest purchase by this insider in our records.
- Buy
Director Jonathan Schechter bought $19K of TWAV at $1.91 — first open-market purchase in our records; raises the stake by 67%.